As demand for increasingly complex TIDES therapeutics continues to rise, developers are looking beyond traditional solid-phase synthesis to improve efficiency, control, and sustainability.
Advances in enzymatic ligation, process analytical technology (PAT), and AI-driven process optimization are opening new possibilities for long-sequence synthesis—enhancing both speed and quality in development.
In this webinar, experts from Asymchem explore how integrated technologies and sustainable methodologies are redefining TIDES process development. They will share practical insights into how combining real-time analytics with data-driven process design can streamline scale-up and improve product consistency.
Key discussion points include:
- How enzymatic methods are extending sequence length and improving overall process sustainability
- The role of PAT and AI in achieving real-time process insight and control
- Strategies for accelerating development timelines while maintaining purity and yield
Meet the Speakers
Dr. Raymond Ye
Senior Vice President
Analytical Development & Operations
Asymchem
Dr. Susan Li
Peptide Chief Scientist
Chemical Macromolecule Division
Asymchem
Dr. Xuecheng Jiao
Vice General Manager
Center of Synthetic Biology Technology
Asymchem

Inspire. Connect. Innovate.